Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Six existing drugs may help block virus entry in COVID-19.

DA-9401 helps protect rat testis from finasteride damage.

North American ginseng extract helped regrow hair in balding mice.

Potassium iodide prevents hair loss and reduces toxicity from thallium acetate.

PRP works faster and is a safe alternative to steroids for treating alopecia areata.

Using isotretinoin gel and minoxidil solution together effectively regrows hair in most people with patchy hair loss.

Low-dose oral minoxidil improved hair growth when topical treatments failed.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Valproic acid is an effective and safe first-choice treatment for many types of seizures.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

Beta-sitosterol and stigmasterol might help prevent hair loss by blocking a specific enzyme.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Valproic acid and carbamazepine do not change biotin or biotinidase levels but may lower zinc levels, still within normal range.

Cetosomal minoxidil alone and with finasteride is effective and well-tolerated for hair loss treatment.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Animal models are crucial for learning about hair loss and finding treatments.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.